Literature DB >> 10098919

Depression during the longitudinal course of schizophrenia.

J R Sands1, M Harrow.   

Abstract

This prospective research investigated the occurrence and persistence of depression during the longitudinal course of schizophrenia. The research goals were to (1) compare depression in schizophrenia with that in schizoaffective and major depressive disorders, (2) assess whether some schizophrenia patients are vulnerable to depression, and (3) assess the relationship of depression to posthospital adjustment in schizophrenia. A total of 70 schizophrenia, 31 schizoaffective depressed, 17 psychotic unipolar major depressed, and 69 nonpsychotic unipolar major depressed patients were assessed during hospitalization and prospectively assessed for depression, psychosis, and posthospital functioning at 4.5- and 7.5-year followups. A large number (30% to 40%) of schizophrenia patients evidenced full depressive syndromes at each followup, including a subgroup of patients who evidenced repeated depression. Even when considering the influence of psychosis on outcome, depression in schizophrenia was associated with poor overall outcome, work impairment, lower activity, dissatisfaction, and suicidal tendencies. During the post-acute phase assessed, neither the rates nor the severity of depressive syndromes differentiated depression in schizophrenia from schizodepressive or major depressive disorders. However, the depressed schizophrenia patients showed poorer posthospital adjustment in terms of less employment, more rehospitalizations, and more psychosis than the patients with primary major depression. The high prevalence of depression in schizophrenia warrants its incorporation into theory about the disorder. A continuum of vulnerability to depression contributes to the heterogeneity of schizophrenia, with some schizophrenia patients being prone to depression even years after the acute phase. Depression in schizophrenia is one factor, in addition to psychosis, associated with poor outcome and requires specific attention to the treatment strategies by psychiatrists.

Entities:  

Mesh:

Year:  1999        PMID: 10098919     DOI: 10.1093/oxfordjournals.schbul.a033362

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  32 in total

Review 1.  Instruments measuring behavioral disturbance in relatives with schizophrenia.

Authors:  H L Provencher; J P Fournier; M Perreault; J Vezina
Journal:  Community Ment Health J       Date:  2000-06

2.  Is schizoaffective disorder a stable diagnostic category: a retrospective examination.

Authors:  Patricia M Averill; Deborah L Reas; Andrew Shack; Nurun N Shah; Katherine Cowan; Kenneth Krajewski; Charles Kopecky; Robert W Guynn
Journal:  Psychiatr Q       Date:  2004

3.  Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia.

Authors:  Joshua Chiappelli; Laura M Rowland; S Andrea Wijtenburg; Florian Muellerklein; Malle Tagamets; Robert P McMahon; Frank Gaston; Peter Kochunov; L Elliot Hong
Journal:  Neuropsychopharmacology       Date:  2015-02-27       Impact factor: 7.853

4.  The burden of depressive symptoms in the long-term treatment of patients with schizophrenia.

Authors:  Robert R Conley; Haya Ascher-Svanum; Baojin Zhu; Douglas E Faries; Bruce J Kinon
Journal:  Schizophr Res       Date:  2006-11-15       Impact factor: 4.939

Review 5.  Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.

Authors:  Max Birchwood; Zaffer Iqbal; Rachel Upthegrove
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

6.  Disconnection Between Amygdala and Medial Prefrontal Cortex in Psychotic Disorders.

Authors:  Prerona Mukherjee; Amri Sabharwal; Roman Kotov; Akos Szekely; Ramin Parsey; Deanna M Barch; Aprajita Mohanty
Journal:  Schizophr Bull       Date:  2016-02-23       Impact factor: 9.306

7.  Agomelatine for Depression in Schizophrenia: A Case-Series.

Authors:  Jochen Mutschler; Nicolas Rüsch; Herdis Schönfelder; Uwe Herwig; Annette B Brühl; Martin Grosshans; Wulf Rössler; Heike Russmann
Journal:  Psychopharmacol Bull       Date:  2012-02-15

8.  Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.

Authors:  Emma E M Knowles; Samuel R Mathias; Godfrey D Pearlson; Jennifer Barrett; Josephine Mollon; Dominique Denbow; Katrina Aberzik; Molly Zatony; David C Glahn
Journal:  Schizophr Res       Date:  2018-10-26       Impact factor: 4.939

9.  Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms.

Authors:  Daniel Fulford; Tara A Niendam; Erin G Floyd; Cameron S Carter; Daniel H Mathalon; Sophia Vinogradov; Barbara K Stuart; Rachel L Loewy
Journal:  Schizophr Res       Date:  2013-04-12       Impact factor: 4.939

10.  Emotional experience predicts social adjustment independent of neurocognition and social cognition in schizophrenia.

Authors:  Ivy F Tso; Tyler B Grove; Stephan F Taylor
Journal:  Schizophr Res       Date:  2010-01-03       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.